FrancophonIA/ELRC3.0 huggingface dataset:
English: Spinraza is a synthetic anti-sense oligonucleotide (a type of genetic material) that enables the SMN2 gene to produce full length protein, which is able to work normally.
Slovenian: Zdravilo Spinraza je sintetični protismiselni oligonukleotid (vrsta genetskega materiala), ki genu SMN2 omogoči tvorbo beljakovine s celotno dolžino in normalnim delovanjem.
English: Spinraza contains the active substance nusinersen.
Slovenian: Zdravilo Spinraza vsebuje zdravilno učinkovino nusinersen.
English: How is Spinraza used?
Slovenian: Kako se zdravilo Spinraza uporablja?
English: How does Spinraza work?
Slovenian: Kako zdravilo Spinraza deluje?
English: Treatment should be continued for as long as the patient benefits from it. For further information, see the package leaflet.
Slovenian: Zdravljenje z zdravilom Spinraza se nadaljuje tako dolgo, dokler je za bolnika koristno.
English: Other opportunistic infections
Slovenian: Druge oportunistične okužbe
English: You and your doctor should pay special attention to signs of infection while you are being treated with Hyrimoz.
Slovenian: Vi sami in vaš zdravnik morata biti posebej pozorna na znake okužbe, medtem ko ste zdravljeni z zdravilom Hyrimoz.
English: If you have any questions, please talk to a doctor, pharmacist or nurse who is familiar with Hyrimoz.
Slovenian: Če imate kakršna koli vprašanja, se pogovorite z zdravnikom, farmacevtom ali medicinsko sestro, ki so seznanjeni z zdravilom Hyrimoz.
English: Side effects may occur up to 4 months or more after the last Hyrimoz injection.
Slovenian: Neželeni učinki se lahko pojavijo do 4 mesece ali več po zadnji injekciji zdravila Hyrimoz.
English: Active tuberculosis or other severe infections such as sepsis, and opportunistic infections (see section 4.4).
Slovenian: Aktivna tuberkuloza ali druge hude okužbe, npr. sepsa, in oportunistične okužbe (glejte poglavje 4.4).
English: Keep this Patient Reminder Card with you during your treatment and for 4 months after your (or your child's) last injection of Hyrimoz.
Slovenian: To opozorilno kartico za bolnika imejte pri sebi med zdravljenjem in še štiri mesece po svoji zadnji injekciji (ali zadnji injekciji vašega otroka) zdravila Hyrimoz.
English: If you accidentally inject Hyrimoz more frequently than you should, call your doctor or pharmacist and explain that you have taken more than required.
Slovenian: Če pomotoma injicirate zdravilo Hyrimoz pogosteje, kot bi smeli, se morate posvetovati z zdravnikom ali s farmacevtom in mu pojasniti, da ste uporabili večji odmerek, kot ga potrebujete.
English: • If you are over 65 years you may be more susceptible to infections while taking Hyrimoz.
Slovenian: • Če ste starejši od 65 let, ste morda dovzetnejši za okužbe, če jemljete zdravilo Hyrimoz.
English: In all situations described below, the benefit / risk balance of therapy should be very carefully considered.
Slovenian: V vseh spodaj opisanih okoliščinah je treba korist in tveganje zdravljenja z zdravilom Hyrimoz zelo natančno pretehtati.
English: • On rare occasions, treatment with Hyrimoz could result in lupus-like syndrome.
Slovenian: • V redkih primerih zdravljenje z zdravilom Hyrimoz povzroči lupusu podoben sindrom.
English: The decision to stop using Hyrimoz should be discussed with your doctor.
Slovenian: O odločitvi, da bi prenehali uporabljati zdravilo Hyrimoz, se morate posvetovati s svojim zdravnikom.
English: Treatment with Hyrimoz can be initiated in combination with corticosteroids and/or with other non-biologic immunomodulatory agents.
Slovenian: Zdravljenje z zdravilom Hyrimoz se lahko začne v kombinaciji s kortikosteroidi in/ali z drugimi nebiološkimi imunomodulatorji.
English: For patients who test positive for hepatitis B infection, consultation with a physician with expertise in the treatment of hepatitis B is recommended.
Slovenian: Pri bolnikih, ki so pozitivni na okužbo s hepatitisom B, se priporoča posvetovanje z zdravnikom specialistom za zdravljenje okužb s hepatitisom B.
English: Hyrimoz in combination with methotrexate, is indicated for:
Slovenian: Zdravilo Hyrimoz je v kombinaciji z metotreksatom indicirano za:
English: • Certain vaccines contain living but weakened forms of disease-causing bacteria or viruses and should not be given during treatment with Hyrimoz in case they cause infections.
Slovenian: • Določena cepiva lahko vsebujejo žive, vendar oslabljene oblike bakterij ali virusov, ki povzročajo bolezen, in teh cepiv se med zdravljenjem z zdravilom Hyrimoz ne sme uporabljati, da ne bi povzročila okužb.
English: If you receive Hyrimoz while you are pregnant, your baby may be at higher risk for getting an infection for up to about five months after the last dose you received during pregnancy.
Slovenian: Če prejemate zdravilo Hyrimoz med nosečnostjo, obstaja večje tveganje, da bo vaš otrok dobil okužbo do približno pet mesecev po zadnjem odmerku, ki ste ga prejeli med nosečnostjo.
English: If you forget to give yourself an injection, you should inject the next dose of Hyrimoz as soon as you remember.
Slovenian: Če si pozabite dati injekcijo, si morate naslednji odmerek zdravila Hyrimoz injicirati, čim se spomnite.
English: • As cases of tuberculosis have been reported in patients treated with adalimumab, your doctor will check you for signs and symptoms of tuberculosis before starting Hyrimoz.
Slovenian: • Ker so bili pri bolnikih, zdravljenih z adalimumabom, opisani primeri tuberkuloze, vas bo zdravnik pred začetkom zdravljenja z zdravilom Hyrimoz preiskal glede znakov in simptomov tuberkuloze.
English: Contents of the pack and other information What Hyrimoz contains
Slovenian: Vsebina pakiranja in dodatne informacije Kaj vsebuje zdravilo Hyrimoz
English: Hyrimoz can also be given alone.
Slovenian: Zdravilo Hyrimoz se lahko daje tudi samo.
English: • If you have allergic reactions with symptoms such as chest tightness, wheezing, dizziness, swelling or rash, do not inject more Hyrimoz and contact your doctor immediately, since in rare cases, these reactions can be life-threatening.
Slovenian: • Če imate alergijske reakcije s simptomi, kot so tiščanje v prsih, piskajoče dihanje, omotica, otekanje ali izpuščaj, zdravila Hyrimoz ne injicirajte več in se takoj posvetujte s svojim zdravnikom, saj so v redkih primerih te reakcije lahko življenje ogrožajoče.
English: Patients on Hyrimoz may receive concurrent vaccinations, except for live vaccines.
Slovenian: Bolniki, ki prejemajo zdravilo Hyrimoz, lahko sočasno dobijo cepiva, razen živih cepiv.
English: Your doctor may recommend temporarily stopping Hyrimoz.
Slovenian: Vaš zdravnik bo morda priporočil začasno prekinitev uporabe zdravila Hyrimoz.
English: By attaching to TNFα, Hyrimoz blocks its action and reduces the inflammation in these diseases.
Slovenian: Z vezavo na TNFα zdravilo Hyrimoz zavre njegovo delovanje in zmanjša vnetni proces pri teh boleznih.
English: • If you receive Hyrimoz during your pregnancy, your baby may have a higher risk for getting an infection.
Slovenian: • Če prejmete zdravilo Hyrimoz med nosečnostjo, obstaja večje tveganje, da bo vaš dojenček dobil okužbo.
English: Before initiation of therapy with Hyrimoz, all patients must be evaluated for both active and inactive (“latent”) tuberculosis infection.
Slovenian: Pred začetkom zdravljenja z zdravilom Hyrimoz je vse bolnike treba pregledati glede aktivne in neaktivne (latentne) tuberkulozne okužbe.
English: The impact of long-term treatment with adalimumab on the development of autoimmune diseases is unknown.
Slovenian: Vpliv dolgoročnega zdravljenja z adalimumabom na nastanek avtoimunskih bolezni ni znan.
English: If active tuberculosis is diagnosed, Hyrimoz therapy must not be initiated (see section 4.3).
Slovenian: Če se odkrije aktivna tuberkuloza, se zdravljenja z zdravilom Hyrimoz ne sme začeti (glejte poglavje 4.3).
English: Treatment with Hyrimoz should not be initiated in patients with active infections including chronic or localised infections until infections are controlled.
Slovenian: Zdravljenja z zdravilom Hyrimoz se ne sme začeti pri bolnikih z aktivnimi okužbami, vključno s kroničnimi ali lokaliziranimi, dokler te niso obvladane.
English: The potential risk with the combination of azathioprine or 6mercaptopurine and Hyrimoz should be carefully considered.
Slovenian: Potrebno je upoštevati potencialno tveganje pri sočasni uporabi azatioprina ali 6-merkaptopurina in zdravila Hyrimoz.
English: Keep Hyrimoz and all medicines out of the reach of children.
Slovenian: Zdravilo Hyrimoz in vsa zdravila shranjujte nedosegljivo otrokom.
English: • When needed (for example when you are travelling), Hyrimoz may be stored at room temperature (up to 25°C) for a maximum period of 14 days - be sure to protect it from light.
Slovenian: • Če je potrebno (na primer kadar potujete), lahko zdravilo Hyrimoz hranite pri sobni temperaturi (do 25 °C) največ 14 dni - zagotovite, da bo zaščiteno pred svetlobo.
English: You should not take Hyrimoz with medicines containing the active substances anakinra or abatacept due to increased risk of serious infection.
Slovenian: Zdravila Hyrimoz ne smete jemati z zdravili, ki vsebujejo učinkovini anakinro ali abatacept zaradi povečanega tveganja za resne okužbe.
English: Other medicines and Hyrimoz
Slovenian: Druga zdravila in zdravilo Hyrimoz
English: Concomitant corticosteroids may be tapered in accordance with clinical practice starting two weeks after initiating treatment with Hyrimoz.
Slovenian: Kortikosteroide, ki se jih daje sočasno, se lahko postopoma ukinja v skladu s klinično prakso, z začetkom dva tedna po začetku zdravljenja z zdravilom Hyrimoz.
English: What you need to know before you use Hyrimoz Do not use Hyrimoz
Slovenian: Kaj morate vedeti, preden boste uporabili zdravilo Hyrimoz Ne uporabljajte zdravila Hyrimoz
English: Use of anti-tuberculosis prophylaxis treatment should also be considered before the initiation of Hyrimoz in patients with several or significant risk factors for tuberculosis despite a negative test for tuberculosis and in patients with a past history of latent or active tuberculosis in whom an adequate course of treatment cannot be confirmed.
Slovenian: O uporabi protituberkuloznega profilaktičnega zdravljenja morate pred uvedbo zdravila Hyrimoz razmisliti tudi pri bolnikih s hudimi ali pomembnimi faktorji tveganja za tuberkulozo kljub negativnemu testu za tuberkulozo in pri bolnikih z anamnezo latentne ali aktivne tuberkuloze, pri katerih ni mogoče potrditi ustreznega zdravljenja.
English: What Hyrimoz is and what it is used for
Slovenian: Kaj je zdravilo Hyrimoz in za kaj ga uporabljamo
English: What Hyrimoz is and what it is used for What you need to know before you use Hyrimoz How to use Hyrimoz
Slovenian: Kaj je zdravilo Hyrimoz in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo Hyrimoz Kako uporabljati zdravilo Hyrimoz
English: Thus additional caution should be exercised in considering Hyrimoz treatment of these patients (see section 4.8).
Slovenian: Torej je potrebna dodatna previdnost, kadar razmišljamo o zdravljenju z zdravilom Hyrimoz pri teh bolnikih (glejte poglavje 4.8).
English: In patients who develop HBV reactivation, Hyrimoz should be stopped and effective anti-viral therapy with appropriate supportive treatment should be initiated.
Slovenian: Pri bolnikih, ki se jim pojavi reaktivacija HBV, je treba uporabo zdravila Hyrimoz prekiniti in uvesti učinkovito protivirusno terapijo z ustreznim podpornim zdravljenjem.
English: You should continue to inject Hyrimoz for as long as your doctor has told you.
Slovenian: Nadaljevati morate z injiciranjem zdravila Hyrimoz tako dolgo, kot vam je naročil zdravnik.
English: Should treatment be interrupted, Hyrimoz may be re-introduced as appropriate.
Slovenian: Če je treba zdravljenje prekiniti, je možno zdravljenje z zdravilom Hyrimoz znova uvesti, kakor je primerno.
English: If latent tuberculosis is diagnosed, appropriate treatment must be started with anti-tuberculosis prophylaxis treatment before the initiation of Hyrimoz, and in accordance with local recommendations.
Slovenian: Če ugotovite latentno tuberkulozo, morate pred uvedbo zdravila Hyrimoz začeti s protituberkuloznim profilaktičnim zdravljenjem v skladu z lokalnimi priporočili.
English: Hyrimoz treatment should be initiated and supervised by specialist physicians experienced in the diagnosis and treatment of conditions for which Hyrimoz is indicated.
Slovenian: Zdravljenje z zdravilom Hyrimoz mora uvesti in nadzorovati zdravnik specialist, izkušen v diagnosticiranju in zdravljenju bolezni, za katere je zdravilo Hyrimoz indicirano.
English: If a patient develops symptoms suggestive of a lupus-like syndrome following treatment with Hyrimoz and is positive for antibodies against double-stranded DNA, further treatment with Hyrimoz should not be given (see section 4.8).
Slovenian: Če se bolniku po zdravljenju z zdravilom Hyrimoz pojavijo simptomi, ki nakazujejo lupusu podobni sindrom, in ima pozitivna protitelesa proti dvojnoverižni DNA, zdravljenja z zdravilom Hyrimoz ne sme nadaljevati (glejte poglavje 4.8).
English: Detailed instructions on how to inject Hyrimoz are provided in section 7, “Instructions for use”.
Slovenian: Podrobna navodila za injiciranje zdravila Hyrimoz so navedena v poglavju 7, ''Navodila za uporabo''.
English: Other serious infections seen in clinical trials include pneumonia, pyelonephritis, septic arthritis and septicaemia.
Slovenian: Med drugimi resnimi okužbami, zabeleženimi v kliničnih preskušanjih, so bile pljučnica, pielonefritis, septični artritis in septikemija.
English: • If you are about to have surgery or dental procedures tell your doctor that you are taking Hyrimoz.
Slovenian: • Če boste imeli kirurški poseg ali poseg na zobeh, povejte svojemu zdravniku, da jemljete zdravilo Hyrimoz.
English: A risk for the development of hepatosplenic T-cell lymphoma in patients treated with Hyrimoz cannot be excluded (see section 4.8).
Slovenian: Tveganja za razvoj hepatospleničnega limfoma celic T pri bolnikih, ki dobivajo zdravilo Hyrimoz, ni mogoče izključiti (glejte poglavje 4.8).
English: If you take Hyrimoz the risk of getting lymphoma, leukaemia, or other cancers may increase.
Slovenian: Če uporabljate zdravilo Hyrimoz, se vam lahko poveča tveganje za pojav limfoma, levkemije ali drugih vrst raka.
English: In non-infectious uveitis, corticosteroids or other medicines that influence the immune system may be continued while using Hyrimoz.
Slovenian: V primeru neinfekcijskega uveitisa se kortikosteroidi ali druga zdravila, ki zavirajo imunski sistem lahko še nadalje uporabljajo ob uporabi zdravila Hyrimoz.
English: • If you have an infection, including long-term or localised infection (for example leg ulcer), consult your doctor before starting Hyrimoz.
Slovenian: • Če imate kakšno okužbo, vključno z dolgotrajno ali omejeno okužbo (npr. razjedo na nogi), se pred uporabo zdravila Hyrimoz posvetujte s svojim zdravnikom.
English: A single Hyrimoz pre-filled syringe / pre-filled pen may be stored at temperatures up to a maximum of 25°C for a period of up to 14 days.
Slovenian: Posamezna napolnjena injekcijska brizga ali napolnjen injekcijski peresnik zdravila Hyrimoz se lahko shranjuje pri temperaturi do največ 25 ºC za obdobje do 14 dni.
English: Tell your doctor if you are taking azathioprine or mercaptopurine with Hyrimoz.
Slovenian: Povejte zdravniku, če prejemate azatioprin ali merkaptopurin sočasno z zdravilom Hyrimoz.
English: Hyrimoz can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate.
Slovenian: Zdravilo Hyrimoz je mogoče uporabiti kot monoterapijo v primeru intolerance za metotreksat ali kadar nadaljnje zdravljenje z metotreksatom ni primerno.
English: Patients treated with Hyrimoz should be given the Patient Reminder Card.
Slovenian: Bolniki, ki se zdravijo z zdravilom Hyrimoz, morajo dobiti opozorilno kartico za bolnika.
English: If an anaphylactic reaction or other serious allergic reaction occurs, administration of Hyrimoz should be discontinued immediately and appropriate therapy initiated.
Slovenian: Če se pojavi anafilaktična reakcija ali kakšna druga resna alergijska reakcija, je treba uporabo zdravila Hyrimoz nemudoma prekiniti in uvesti ustrezno zdravljenje.
English: Hyrimoz is used to treat Crohn's disease in adults and children aged 6 to 17 years.
Slovenian: Zdravilo Hyrimoz se uporablja za zdravljenje Crohnove bolezni pri odraslih in otrocih, starih od 6 do 17 let.
English: Patients must therefore be monitored closely for infections, including tuberculosis, before, during and after treatment with Hyrimoz.
Slovenian: Bolnike je zato treba pred, med in po zdravljenju z zdravilom Hyrimoz natančno kontrolirati glede okužb, vključno s tuberkulozo.
English: The active ingredient in Hyrimoz, adalimumab, is a monoclonal antibody.
Slovenian: Učinkovina v zdravilu Hyrimoz, adalimumab, je monoklonsko protitelo.
English: Taking these results into consideration, Hyrimoz is recommended for use in combination with MTX and for use as monotherapy in patients for whom MTX use is not appropriate (see section 4.2).
Slovenian: Z upoštevanjem teh ugotovitev je zdravilo Hyrimoz priporočljivo uporabljati v kombinaciji z metotreksatom, kot monoterapijo pa pri bolnikih, za katere uporaba metotreksata ni primerna (glejte poglavje 4.2).
English: Alternatively, if a patient has stopped Hyrimoz and signs and symptoms of disease recur, Hyrimoz may be re-administered.
Slovenian: Če bolnik neha uporabljati zdravilo Hyrimoz, pa se znaki in simptomi bolezni ponovijo, je mogoče zdravilo Hyrimoz znova uvesti.
English: Hyrimoz contains the active substance adalimumab, a medicine that acts on your body's immune (defence) system.
Slovenian: Zdravilo Hyrimoz vsebuje učinkovino adalimumab, ki deluje na imunski sistem (obrambni mehanizem) telesa.
English: It is important that you tell your baby's doctors and other health care professionals about your Hyrimoz use during your pregnancy so they can decide when your baby should receive any vaccine.
Slovenian: Zato je pomembno, da obvestite zdravnika vašega otroka in druge zdravstvene delavce, da ste med nosečnostjo prejemali zdravilo Hyrimoz, da se lahko odločijo, kdaj bo vaš otrok lahko prejel katerokoli cepivo.
English: Hyrimoz is used to treat polyarticular juvenile idiopathic arthritis in children and adolescents aged 2 to 17 years and enthesitis-related arthritis in children and adolescents aged 6 to 17 years.
Slovenian: Zdravilo Hyrimoz se uporablja za zdravljenje poliartikularnega juvenilnega idiopatskega artritisa pri otrocih in mladostnikih, starih 2 do 17 let in artritisa, povezanega z entezitisom pri otrocih in mladostnikih starih od 6 do 17 let.
English: • Hyrimoz should only be used during a pregnancy if needed.
Slovenian: • Zdravilo Hyrimoz se med nosečnostjo lahko uporablja samo, če je potrebno.
English: If you use more Hyrimoz than you should
Slovenian: Če ste uporabili večji odmerek zdravila Hyrimoz, kot bi smeli
English: Patients who develop a new infection while undergoing treatment with Hyrimoz should be monitored closely and undergo a complete diagnostic evaluation.
Slovenian: Bolnike, pri katerih se med zdravljenjem z zdravilom Hyrimoz pojavi nova okužba, je treba natančno nadzirati in opraviti morajo popolno diagnostično obravnavo.
English: Hyrimoz 40 mg solution for injection in pre-filled pen EU/1/18/1286/004
Slovenian: Hyrimoz 40 mg raztopina za injiciranje v napolnjenem injekcijskem peresniku EU/1/18/1286/004
English: Hyrimoz can also be used to treat severe, active and progressive rheumatoid arthritis without previous methotrexate treatment.
Slovenian: Zdravilo Hyrimoz je mogoče uporabljati tudi za zdravljenje hudega, aktivnega in napredujočega revmatoidnega artritisa brez predhodnega zdravljenja z metotreksatom.
English: Despite prophylactic treatment for tuberculosis, cases of reactivated tuberculosis have occurred in patients treated with adalimumab.
Slovenian: Kljub profilaktičnemu zdravljenju za tuberkulozo, so se pri bolnikih, zdravljenih z adalimumabom, pojavili primeri reaktivacije tuberkuloze.
English: Women of childbearing potential should consider the use of adequate contraception to prevent pregnancy and continue its use for at least five months after the last Hyrimoz treatment.
Slovenian: Ženske v rodni dobi morajo premisliti o uporabi ustrezne kontracepcijske zaščite za preprečitev nosečnosti in z njo nadaljevati vsaj še pet mesecev po zadnjem zdravljenju z zdravilom Hyrimoz.
English: Hyrimoz is also used to treat severe plaque psoriasis in children and adolescents aged 4 to 17 years for whom medicines applied to the skin and treatment with UV light have either not worked very well or are not suitable.
Slovenian: Zdravilo Hyrimoz se uporablja tudi za zdravljenje hude luskavice v plakih pri otrocih in mladostnikih, starih od 4 do 17 let, pri katerih zdravila, ki se nanašajo na kožo, in zdravljenje z UV-svetlobo niso dovolj dobro delovali ali pa niso primerni.
English: These infections may be more serious and include tuberculosis, infections caused by viruses, fungi, parasites or bacteria, or other unusual infectious organisms and sepsis (blood poisoning).
Slovenian: Te okužbe so lahko resne in vključujejo tuberkulozo, okužbe, ki jih povzročijo virusi, glive, paraziti ali bakterije ali drugi nenavadni kužni organizmi, in sepso (zastrupitev krvi).
English: Treatment with Hyrimoz may result in the formation of autoimmune antibodies.
Slovenian: Zdravljenje z zdravilom Hyrimoz lahko povzroči nastanek avtoimunskih protiteles.
English: Hyrimoz can be given as monotherapy in case of intolerance to methotrexate or when continued treatment with methotrexate is inappropriate (for the efficacy in monotherapy see section 5.1).
Slovenian: Zdravilo Hyrimoz je mogoče uporabiti kot monoterapijo v primeru intolerance za metotreksat ali kadar nadaljnje zdravljenje z metotreksatom ni primerno (za učinkovitost monoterapije glejte poglavje 5.1).
English: Patients should be tested for HBV infection before initiating treatment with Hyrimoz.
Slovenian: Bolnike je treba pred začetkom zdravljenja z zdravilom Hyrimoz testirati na okužbo s HBV.
English: Hyrimoz is a biosimilar medicinal product.
Slovenian: Zdravilo Hyrimoz je podobno biološko zdravilo.
English: If you have mild heart failure and you are being treated with Hyrimoz, your heart failure status must be closely monitored by your doctor.
Slovenian: Če imate blago srčno popuščanje in se zdravite z zdravilom Hyrimoz, mora zdravnik natančno nadzorovati stanje vašega srčnega popuščanja.
English: Hyrimoz may have a minor influence on the ability to drive and use machines.
Slovenian: Zdravilo Hyrimoz ima lahko blag vpliv na sposobnost vožnje in upravljanja strojev.
English: After proper training in injection technique, patients may self-inject with Hyrimoz if their physician determines that it is appropriate and with medical follow-up as necessary.
Slovenian: Bolniki, ki se naučijo pravilnega postopka injiciranja, si zdravilo Hyrimoz lahko injicirajo sami, če zdravnik presodi, da je to primerno, in je zagotovljeno ustrezno medicinsko spremljanje.
English: 5 How to store Hyrimoz Contents of the pack and other information Instructions for use
Slovenian: 5 Shranjevanje zdravila Hyrimoz Vsebina pakiranja in dodatne informacije Navodila za uporabo
English: Usually, Hyrimoz is used with methotrexate.
Slovenian: Zdravilo Hyrimoz ponavadi uporabljamo z metotreksatom.
English: Hyrimoz may have a minor influence on your ability to drive, cycle or use machines.
Slovenian: Zdravilo Hyrimoz ima lahko blag vpliv na sposobnost vožnje, kolesarjenja ali upravljanja strojev.
English: It is recommended that, if possible, children be given all the scheduled vaccinations for their age before they start treatment with Hyrimoz.
Slovenian: Za otroke je priporočljivo, da pred začetkom zdravljenja z zdravilom Hyrimoz prejmejo vsa cepljenja, predvidena za njihovo starost, če je le mogoče.
English: In rheumatoid arthritis, methotrexate is continued while using Hyrimoz.
Slovenian: Pri revmatoidnem artritisu se uporaba metotreksata med uporabo zdravila Hyrimoz nadaljuje.